1e
19
1
49
2
2
18
1b
1d
18
34
86
1d
2 29
1d
25
Daniel M. Kolansky, MD
78
86
Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania
28
78
3
5f
Attending in Medicine, Hospital of the University of Pennsylvania
90
Attending, Cardiac Catheterization Laboratory, Hospital of the University of Pennsylvania
7b
Attending, University Associate, Children's Hospital of Philadelphia
84
Attending, Cardiac Catheterization Laboratory, Philadelphia VA Medical Center
7e
Director, Cardiac Care Unit, Hospital of the University of Pennsylvania
83
Unit Based Clinical Leader, CICU, Hospital of the University of Pennsylvania
82
Unit Based Clinical Leader, CCU, Hospital of the University of Pennsylvania
71
Courtesy Attending Staff, Penn Presbyterian Medical Center
ac
Associate Chief for Clinical Affairs, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania
8e
Medical Director, Heart and Vascular Center, Hospital of the University of Pennsylvania
11
Department: Medicine
4
1
b
1d
46
Contact information
65
4
3
3
1d
65
Perelman School of Medicine, University of Pennsylvania
1e 11th Floor South Tower
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
1e 11th Floor South Tower
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
2e
Office: 215-662-2178
32 Fax: 215-615-3073
24
ad
12
32 Fax: 215-615-3073
24
18
Publications
23 a
3
2
29
4
b
1f
23 a
13
Education:
21 7 BA 1a (Human Biology) c
2c Stanford University, 1980.
21 7 MD 15 (Medicine) c
28 Yale University, 1984.
c
3
3
3
3
8b
Permanent link21 7 BA 1a (Human Biology) c
2c Stanford University, 1980.
21 7 MD 15 (Medicine) c
28 Yale University, 1984.
c
2 29
21
1e
1d
24
5e
65
1a 29
27
Description of Research Expertise
90 therapeutic hypothermia after cardiac arrest, cardiac catheterization and coronary intervention, CAD and familial hyperlipidemia65
Description of Clinical Expertise
a0 coronary angioplasty and stenting, cardiac catheterization, treatment of coronary and valvular heart disease, treatment of myocardial infarction1a 29
23
17a Abudayyeh I, Dupont AG, Hermiller JB, Mascarenhas J, Velagapudi P, Ijioma NN, Duffy PL, Kolansky DM, Cigarroa J, Scantlebury DC, Skelding K, Klein AJ.: Occupational Health Hazards in the Cardiac Catheterization Laboratory: Results of the 2023 SCAI Survey. J Soc Cardiovasc Angiogr Interv 4(4), March 2025.
19a Smeijer JD, Koomen J, Kohan DE, McMurray JJV, Bakris GL, Correa-Rotter R, Hou F-F, Januzzi JL , Kitzman DW, Kolansky DM, Makino H, Perkovic V, Tobe S, Parving H-H, de Zeeuw D, Heerspink HJL: Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. J Am Coll Cardiol HF May 2022.
143 Lee G, Varughese LA, Conway L, Stojinski C, Ashokkumar S, Monono K, Matthai W, Kolansky DM, Giri J, Tuteja S.: Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention. Per Med. March 2022.
180 Nathan AS, Geng Z, Eberly LA, Eneanya ND, Dayoub EJ, Khatana SAM, Kolansky DM, Kobayashi TJ, Tuteja S, Fanaroff AC, Giri J, Groeneveld PW.: Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention. J Invasive Cardiology March 2022.
122 Hoffecker G, Kanter GP, Xu Y, Matthai W, Kolansky DM, Giri J, Tuteja S.: Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions. Per Med. January 2022.
14f Johnson BV, Horton ER, Domenico C, Nathan AS, Fanaroff, AC, Acker, MA, Kolansky DM: Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective Study. J Invasive Cardiology 33(12): E998-E1003, December 2021.
167 Dayoub EJ, Nathan AS, Khatana SAM, Wadhera RK, Kolansky DM, Yeh RW, Giri J, Groeneveld PW.: Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria. Circ Cardiovasc Qual Outcomes 27 14(4), April 2021.
15e Adusumalli S, Jolly E, Chokshi NP, Gitelman Y, Rareshide CAL, Kolansky DM, Patel MS.: Referral Rates for Cardiac Rehabilitation Among Eligible Inpatients After Implementation of a Default Opt-Out Decision Pathway in the Electronic Medical Record. JAMA Netw Open 4(1), Jan 2021.
22a Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, Snider C, Chokshi NP, Eneanya ND, Takvorian SU, Anastos-Wallen R, Chaiyachati K, Ambrose M, O'Quinn R, Seigerman M, Goldberg LR, Leri D, Choi K, Gitelman Y, Kolansky DM, Cappola TP, Ferrari VA, Hanson CW, Deleener ME, Adusumalli S.: Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Network Open 3(12): e2031640, December 2020.
2c
7
1d
1f
Selected Publications
19b Nathan AS, Kennedy KF, Reddy KP, Fanaroff AC, Kolansky DM, Kobayashi TJ, Khatana SAM, Dayoub EJ, Eberly L, Rao SV, Mehran R, Bhatt D, Yeh RW, Spertus JA, Giri J.: Variation in Likelihood of Undergoing Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Among US Hospitals. J Am Heart Assoc 14(5), March 2025.17a Abudayyeh I, Dupont AG, Hermiller JB, Mascarenhas J, Velagapudi P, Ijioma NN, Duffy PL, Kolansky DM, Cigarroa J, Scantlebury DC, Skelding K, Klein AJ.: Occupational Health Hazards in the Cardiac Catheterization Laboratory: Results of the 2023 SCAI Survey. J Soc Cardiovasc Angiogr Interv 4(4), March 2025.
19a Smeijer JD, Koomen J, Kohan DE, McMurray JJV, Bakris GL, Correa-Rotter R, Hou F-F, Januzzi JL , Kitzman DW, Kolansky DM, Makino H, Perkovic V, Tobe S, Parving H-H, de Zeeuw D, Heerspink HJL: Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure. J Am Coll Cardiol HF May 2022.
143 Lee G, Varughese LA, Conway L, Stojinski C, Ashokkumar S, Monono K, Matthai W, Kolansky DM, Giri J, Tuteja S.: Attitudes toward pharmacogenetics in patients undergoing CYP2C19 testing following percutaneous coronary intervention. Per Med. March 2022.
180 Nathan AS, Geng Z, Eberly LA, Eneanya ND, Dayoub EJ, Khatana SAM, Kolansky DM, Kobayashi TJ, Tuteja S, Fanaroff AC, Giri J, Groeneveld PW.: Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 Inhibitors After Percutaneous Coronary Intervention. J Invasive Cardiology March 2022.
122 Hoffecker G, Kanter GP, Xu Y, Matthai W, Kolansky DM, Giri J, Tuteja S.: Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions. Per Med. January 2022.
14f Johnson BV, Horton ER, Domenico C, Nathan AS, Fanaroff, AC, Acker, MA, Kolansky DM: Safety of Intravenous Cangrelor Administration for Antiplatelet Bridging in Hospitalized Patients: A Retrospective Study. J Invasive Cardiology 33(12): E998-E1003, December 2021.
167 Dayoub EJ, Nathan AS, Khatana SAM, Wadhera RK, Kolansky DM, Yeh RW, Giri J, Groeneveld PW.: Trends in Coded Indications for Percutaneous Coronary Interventions in Medicare and the Veterans Affairs After Implementation of Hospital-Level Reporting of Appropriate Use Criteria. Circ Cardiovasc Qual Outcomes 27 14(4), April 2021.
15e Adusumalli S, Jolly E, Chokshi NP, Gitelman Y, Rareshide CAL, Kolansky DM, Patel MS.: Referral Rates for Cardiac Rehabilitation Among Eligible Inpatients After Implementation of a Default Opt-Out Decision Pathway in the Electronic Medical Record. JAMA Netw Open 4(1), Jan 2021.
22a Eberly LA, Kallan MJ, Julien HM, Haynes N, Khatana SAM, Nathan AS, Snider C, Chokshi NP, Eneanya ND, Takvorian SU, Anastos-Wallen R, Chaiyachati K, Ambrose M, O'Quinn R, Seigerman M, Goldberg LR, Leri D, Choi K, Gitelman Y, Kolansky DM, Cappola TP, Ferrari VA, Hanson CW, Deleener ME, Adusumalli S.: Patient Characteristics Associated With Telemedicine Access for Primary and Specialty Ambulatory Care During the COVID-19 Pandemic. JAMA Network Open 3(12): e2031640, December 2020.
2c